Cost-sharing under Aetna varies: some plans place Zepbound on the highest formulary tier (specialty tier), resulting in copays of $50$250+ per month or coinsurance of 2030% of the actual drug price
I/R-AKI is implicated in cell death and tissue damage across various conditions, including AKI, stroke, and coronary occlusion
Importantly for weight management, these medications also act on receptors in the brainparticularly in the hypothalamusto reduce appetite and increase feelings of satiety
Activity-dependent switch of GABAergic inhibition into glutamatergic excitation in astrocyte-neuron networks
At least one serious adverse event occurred among 10.9% of the 36 mg orforglipron group, 10.3% of the 12 mg orforglipron group, 7.3% of those receiving 6 mg orforglipron and 8.8% of the placebo group
It is important to recognise red flag symptoms that may indicate a more serious underlying condition or complication